In this study, we provided the evidence to show that MYSM1 is required for the association between the HATs complex and ERα, modulating active histone modifications to enhance chromatin accessibility in a serial and combinatorial manner in the breast cancer cellular context (Figs. 4C,D and EV1B). Here, MYSM1 is linked to breast carcinoma.